product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
PITSLRE/CDK11 (D88B3) Rabbit mAb
catalog :
5524
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
D88B3
reactivity :
human, mouse, rat
application :
western blot, immunocytochemistry, immunoprecipitation
more info or order :
Cell Signaling Technology product webpage
citations: 2
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:1000; fig 3
Zhou Y, Han C, Li D, Yu Z, Li F, Li F, et al. Cyclin-dependent kinase 11(p110) (CDK11(p110)) is crucial for human breast cancer cell proliferation and growth. Sci Rep. 2015;5:10433 pubmed publisher
Kren B, Unger G, Abedin M, Vogel R, Henzler C, Ahmed K, et al. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy. Breast Cancer Res. 2015;17:19 pubmed publisher
product information
SKU :
5524S
Product-Name :
PITSLRE/CDK11 (D88B3) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, Mk, (R)
Applications :
Immunofluorescence (Immunocytochemistry)
Product-Category :
Cell Cycle / Checkpoint Control
Shipping-Temp :
COLD
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
110
Host :
Rabbit
Target :
PITSLRE
Primary-Protein :
CDK11B
Alt-Names :
CD11B,CDC-related protein kinase p58,CDC2L1,CDC2L2,CDK11,CDK11-p110,CDK11-p46,CDK11-p58,CDK11B,CDK11p58,CLK-1,Cell division cycle 2-like protein kinase 1,Cell division protein kinase 11B,FLJ59152,Galactosyltransferase-associated protein kinase p58/GTA,PITSLRE,PITSLRE serine/threonine-protein kinase CDC2L1,PITSLREA,PK58,cell division cycle 2-like 1 (PITSLRE proteins),cell division cycle 2-like 2 (PITSLRE proteins),cyclin-dependent kinase 11B,p58,p58 CLK-1,p58CDC2L1,p58CLK-1
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.